Acute intermittent porphyria: a disease with low penetrance and high heterogeneity. [PDF]
Lei JJ, Li S, Dong BX, Yang J, Ren Y.
europepmc +1 more source
Unraveling Complexity: Acute Intermittent Porphyria Complicated by Rhabdomyolysis and Acute Pancreatitis. [PDF]
Norman J, Soliman M.
europepmc +1 more source
German Real-World Experience of Patients with Diverse Features of Acute Intermittent Porphyria Treated with Givosiran. [PDF]
Kubisch I +7 more
europepmc +1 more source
Unveiling the Chameleon: A Case Report on Acute Intermittent Porphyria. [PDF]
Shrestha M +7 more
europepmc +1 more source
A novel <i>HMBS</i> gene mutation in acute intermittent porphyria: a case report of abdominal pain, seizures, and reversible neuroimaging findings. [PDF]
Dong W +7 more
europepmc +1 more source
Baseline urinary ALA and PBG as criteria for starting pharmacologic prophylactic treatment in acute intermittent porphyria treated with givosiran. [PDF]
Kuo HC +5 more
europepmc +1 more source
Human Chorionic Gonadotropin (hCG) Injections Exacerbating Acute Intermittent Porphyria in a 34-Year-Old Woman. [PDF]
Ali M, Iqbal S.
europepmc +1 more source
Xenobiotics Triggering Acute Intermittent Porphyria and Their Effect on Mouse Brain Respiratory Complexes. [PDF]
Zuccoli JR +3 more
europepmc +1 more source
Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates. [PDF]
Córdoba KM +29 more
europepmc +1 more source

